Obesity drugs trim ads

Goetzl, David
August 2001
Advertising Age;8/13/2001, Vol. 72 Issue 33, p10
Trade Publication
The article reports on the decision of obesity drug manufacturers Hoffmann-La Roche and Abbott Pharmaceuticals to discontinue direct-to-consumer (DTC) advertising for their products. Hoffmann-La Roche's new campaign, launched in February 2001, which was designed in part to divert attention from Xenical's possible side effects, failed to increase sales. Abbott, the new owner of the Meridia drug, has also decided to stop all DTC ads.


Related Articles

  • ResearchWatch. Smith, Brian // Journal of Medical Marketing;Jan2009, Vol. 9 Issue 1, p77 

    The article discusses various reports published within the issue, including one which examines the fair balance in direct-to-consumer (DTC) pharmaceutical advertising, one which demonstrates the role of DTC advertising in constructing the social reality of diseases and medicine, and one on the...

  • Draining the bathwater. CHASE, JAMES // Medical Marketing & Media;Apr2013, Vol. 48 Issue 4, p8 

    An introduction to the journal is presented in which the editor discusses various reports within the issue on topics related to direct-to-consumer advertising (DTC) in the pharmaceutical industry.

  • Vantage Point. Kaplan, Harris // Medical Marketing & Media;Oct2012, Vol. 47 Issue 10, p28 

    In this article the author discusses the direct-to-consumer (DTC) drug advertising by pharmaceutical companies to reach directly to patients, instead of relying on physicians to prescribe the drug.

  • Librium Top Tranquilizer.  // Advertising Age;6/23/2008, Vol. 79 Issue 25, pC3 

    The article presents a reprint of the article “Librium Top Tranquilizer,” which appeared in "Advertising Age" in 1960. The author reports on the retail success of the tranquilizer Librium. The amount of money which the company Hoffman-LaRoche anticipated spending on marketing the...

  • Xenical set to debut weighty $75 mil campaign. Goetzl, David // Advertising Age;9/27/1999, Vol. 70 Issue 40, p1 

    The article reports on the planned advertising efforts for Hoffman-La Roche's anti-obesity drug Xenical. The company is set to launch its direct-to-consumer television campaign on October 4, 1999. Accompanying print work will run in weekly magazines. The campaign is from Lowe Consumer...

  • Danes' awareness of and attitude towards direct-to-consumer advertising (DTC-A) of prescription drugs: A quantitative survey of 3,000 respondents. Rehne, Joakim; Møldrup, Claus // Journal of Medical Marketing;Jan2008, Vol. 8 Issue 1, p31 

    The patient's perspective on direct-to-consumer is seldom offered in the literature, even though we want to put patients first in the healthcare system. Therefore, this survey attempts to shed light on the attitudes towards the direct-to-consumer advertising of drugs in the Danish population. A...

  • ResearchWatch. Smith, Brian D. // Journal of Medical Marketing;Mar2008, Vol. 8 Issue 2, p181 

    The article discusses several new management research projects related to the global pharmaceutical industry. They include research about the impact of the Internet on the U.S. pharmaceutical industry, the effects of patent protection on pharmaceutical innovations, and research about the...

  • How to reach consumers in a market where DTC is not allowed. Chang Dae Ham; Jong Woo Jun; Hyung-Seok Lee // Journal of Medical Marketing;Mar2008, Vol. 8 Issue 2, p159 

    This study explores the characteristics of the rapidly changing South Korean (S. Korea) pharmaceutical market, specifically focussing on the erectile dysfunction drug market. The S. Korean drug market is in the middle of a significant transition stemming from a Free Trade Agreement (FTA) with...

  • U.S. Industry Quarterly Review: Chemicals.  // U.S. Industry Quarterly Review: Chemicals;2005 2nd Quarter, p29 

    The article presents an update on the status of the chemicals and pharmaceutical industries in the U.S. as of April 2005 and presents an outlook for the said industries in 2009. The demand for plastic resins has declined on a year-earlier basis through April 2005 and prices have followed suit....


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics